Shares of YY Inc (NYSE:YY) have earned a consensus rating of “Buy” from the nine analysts that are presently covering the company. Three research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock…
CBOE Holdings, Inc. (NASDAQ:CBOE) disclosed its intention to list options derivatives for Alibaba Group Holding Ltd., following the latter’s initial public offering (IPO) on Sep 19 at NYSE, under the symbol BABA. The increased volatility that Alibaba stock is likely to experience attracts the attention of this options exchange. CBOE Holdings, Inc. (NASDAQ:CBOE) belongs to…
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Aug. 15. The shares were purchased at an average price of $5.83 per share, for a total transaction of $4,955,500.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is…
Pacific Crest reaffirmed their outperform rating on shares of YY Inc (NYSE:YY) in a report issued on Thursday. They currently have a $110.00 target price on the stock, up from their previous target price of $93.00. YY Inc. (NASDAQ:YY) belongs to Technology sector. Its net profit margin is 27.40% and weekly performance is -0.43%. On last trading…
